Prognostic Value of [ <sup>18</sup> F]Flotufolastat PET Using Visual RECIP in Docetaxel-Treated Metastatic Prostate Cancer
F]flotufolastat PET assessed using visual RECIP has high prognostic utility in patients with metastatic prostate cancer undergoing CTx.
Authors
- Kristina Schwamborn (ORCID: https://orcid.org/0000-0003-3717-0823)
- Daniel Sasse
- Theo Lorenzini (ORCID: https://orcid.org/0000-0003-3377-032X)
- Florian Siegel (ORCID: https://orcid.org/0000-0003-3741-3004)
- Bernd Erber (ORCID: https://orcid.org/0000-0003-2669-2001)
- J.A. Werner (ORCID: https://orcid.org/0000-0002-6421-4783)
- Sonja Kirchhoff
- Matthias Eiber
- Wolfgang Weber
- Maximilian Keck
- Florian Kirchhoff
- Stephan Beintner-Skawran
- Isabel Rauscher
Institutions
- University of Zurich (CH)
- University Hospital of Zurich (CH)
- Bavarian Nordic (Germany) (DE)
- Technical University of Munich (DE)
- Cochrane (GB)
Publication Details
- Journal
- Journal of Nuclear Medicine
- Published
- 2026-04-22
- DOI
- https://doi.org/10.2967/jnumed.125.271488
- Primary Topic
- Prostate Cancer Treatment and Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00